Semax

Also known as: Heptapeptide SEMAX

CognitivePHASE 2

Clinical Status

Approved in Russia — not FDA approved.

Mechanism of Action

Increases BDNF and NGF expression, modulates dopamine and serotonin systems, and has anti-inflammatory effects in the brain. Enhances neuroplasticity.

Dosing Defaults

Dose

200-600 mcg

Frequency

1-3x daily

Administration

Intranasal spray

Timing

Morning or early afternoon

Food

with or without

Duration

10-30 days

Dose range: 100-900 mcg daily

Morning/afternoon dosing supports cognitive performance during waking hours.

Side Effects

•Nasal irritation
•Headache
•Insomnia
•Increased anxiety (paradoxical in some)
•Nausea

Contraindications & Warnings

•Not medical advice
•Caution with SSRIs and MAOIs

Compare

Compare Semax with another peptide side-by-side.

Calculate Dose

Use the reconstitution calculator to prepare your Semax dose.

Open Calculator

Related Cognitive Peptides

Selank

PHASE 2

Cognitive

Anxiolytic peptide approved in Russia. Non-sedative, non-addictive.

Dihexa

PRECLINICAL

Cognitive

Potent nootropic that promotes synapse formation. No human trials.

Noopept

PHASE 2

Cognitive

Dipeptide-derived nootropic for memory and neuroprotection. Approved in Russia.

P21

PRECLINICAL

Cognitive

Neurogenic peptide that promotes hippocampal neurogenesis in research models.

This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.